Edward DiNapoli

Sr. Director Insights and Solutions at Emergent BioSolutions
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Philadelphia

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Sr. Director Insights and Solutions
      • Jan 2023 - Present

      Greater Philadelphia

    • Sr. Director, Contract Operations and Insights
      • Oct 2021 - Jan 2023

      Greater Philadelphia

    • Director, North American Contract Operations
      • Sep 2020 - Oct 2021

      Greater Philadelphia

    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Vice President, Customer Solutions
      • Jan 2020 - Oct 2021

      Newtown Square

    • Senior Director, Customer Operations & Analytics
      • May 2018 - Jan 2020

      Greater Philadelphia Area

    • United States
    • Pharmaceutical Manufacturing
    • 100 - 200 Employee
    • Director, Forecasting and Advanced Analytics
      • Sep 2016 - May 2018

      Greater Philadelphia Area

    • Australia
    • Biotechnology Research
    • 700 & Above Employee
    • Director, Forecasting and Strategic Analytics
      • Jun 2015 - Sep 2016

      Greater Philadelphia Area

    • Switzerland
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Associate Director, New Product Planning and Launch Optimization
      • Jan 2014 - Jun 2015

      Princeton, New Jersey Developed and implement launch strategies supporting Sandoz' opioid, ophthalmic and dermatology franchise portoflios. This included overseeing and coordinating launch of all products out of US sites ensuring sales targets, regulatory and supply chain KPIs were met. Responsible for coordinating with R&D, IP and Regulatory Affairs to identify new product candidates to be developed for US sites with the objective to grow the opioid, ophthalmic and dermatology portfolios for long-term… Show more Developed and implement launch strategies supporting Sandoz' opioid, ophthalmic and dermatology franchise portoflios. This included overseeing and coordinating launch of all products out of US sites ensuring sales targets, regulatory and supply chain KPIs were met. Responsible for coordinating with R&D, IP and Regulatory Affairs to identify new product candidates to be developed for US sites with the objective to grow the opioid, ophthalmic and dermatology portfolios for long-term, sustained success. Show less

    • Ireland
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Director, Forecasting and Portfolio Management
      • Feb 2013 - Jun 2013

      Greater Philadelphia Area Responsible for the development of commercialization plans for new technologies and their applicability to Endo’s pharmaceutical business. Oversaw commercialization efforts for Endo’s IDD (Implantable Drug Delivery) business. Identified and evaluated on market assets, making recommendations to senior management on strategic fit and value to the pharmaceuticals business.

    • Director, Strategic Growth Initiatives
      • Sep 2011 - Feb 2013

      Greater Philadelphia Area Working within the construct of a new department within the organization, developed business cases in support of innovative ways to pull together the different components (branded pharmaceuticals, generic pharmaceuticals, medical devices, services and data) of Endo's business and provide value to our customers.

    • Director, Forecasting
      • Oct 2010 - Sep 2011

      Greater Philadelphia Area Responsible for leading the forecasting team, providing short-term and strategic forecasts for the in-line product portfolio. Ensured that senior management was aware of key drivers of the business and informed decisions accordingly. Worked with key stakeholders to re-engineer the forecasting process, making sure that business questions were addressed effectively and that improvements in outputs were realized. Led the Price/Volume team (Forecasting, Finance, Managed Markets, Marketing) in… Show more Responsible for leading the forecasting team, providing short-term and strategic forecasts for the in-line product portfolio. Ensured that senior management was aware of key drivers of the business and informed decisions accordingly. Worked with key stakeholders to re-engineer the forecasting process, making sure that business questions were addressed effectively and that improvements in outputs were realized. Led the Price/Volume team (Forecasting, Finance, Managed Markets, Marketing) in providing insights to senior management on key drivers of revenue variances.

    • Israel
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Director, Financial Planning and Analysis
      • May 2010 - Oct 2010

      Greater Philadelphia Area Responsible for presenting monthly and quarterly analyses on performance and forecasts (sales and expenses) to US Generics senior management. Oversight for the budget process for sales and operating expenses across the USGx business, while ensuring communication of key business drivers to global HQ completed effectively. Interacted with multiple stakeholders within US Technical Operations to understand business needs and tailor analyses to help drive the business towards appropriate decisions.

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Director, Global Forecasting
      • Aug 2007 - May 2010

      Greater Philadelphia Area Provided financial management assistance for US Pharmaceuticals and Global Nutritionals portfolio ($11.5B in sales) and forecasted the Protonix family ($1.7B in sales) and Premarin family ($1.1B). Led monthly process of collecting US forecasts for the US Pharmaceuticals business and acted as point in communicating changes and risks/opportunities to US CFO. Worked to define business requirements for consolidation software for Global Forecasting and oversaw the implementation and training… Show more Provided financial management assistance for US Pharmaceuticals and Global Nutritionals portfolio ($11.5B in sales) and forecasted the Protonix family ($1.7B in sales) and Premarin family ($1.1B). Led monthly process of collecting US forecasts for the US Pharmaceuticals business and acted as point in communicating changes and risks/opportunities to US CFO. Worked to define business requirements for consolidation software for Global Forecasting and oversaw the implementation and training on the application. Partnered with regional and global supply chain leadership to conduct a company wide survey to understand learning needs of affiliate forecasters. Partnered with Global Supply Chain to ensure that local, regional and global S&OP processes were in place and met the needs of the business. Helped to lead the successful re-structuring of Global Forecasting to a truly global organization through the identification of required roles & responsibilities and highlighting the appropriate skill sets needed. Show less

    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Senior Consultant
      • Sep 2006 - Aug 2007

      Greater Philadelphia Area As one of the initial consultants, helped laid the groundwork which helped lead PriceSpective into the fastest-growing healthcare consultancy in the US (Inc. Magazine). Was project lead for a number of clients covering medical devices, neurology, oncology, pain, diabetes and schizophrenia. Conducted this market research across both the US and EU payer environments.

    • Pharmaceutical Manufacturing
    • 200 - 300 Employee
    • Associate Director, Business Planning
      • Feb 2002 - Aug 2006

      Greater Philadelphia Area Was responsible for managing brand marketing, forecasting, portfolio analysis and business development for the branded pharmaceuticals business unit. Sat on the new product development team with senior management to review products in development and evaluate potential pipeline product candidates. Worked with cross-functional team on new brand product identification and target product profile generation.

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Technical Analyst
      • Sep 1998 - Feb 2002

      Greater Philadelphia Area

Education

  • Villanova University
    MBA, Marketing
    1998 - 2001
  • Penn State University
    Bachelor of Science (BS)
    1991 - 1995

Community

You need to have a working account to view this content. Click here to join now